Health Industry Updates: Investments, Probes, and Innovations

In a significant move, Britain's government has decided not to bail out its struggling bioethanol industry, a sector that employs thousands and has been severely impacted by the UK's trade deal with the U.S. under former President Donald Trump. This decision may cause political discomfort for Prime Minister Keir Starmer, who had previously championed the agreement as beneficial for businesses.

Business mogul Warren Buffett's Berkshire Hathaway has made headlines with its investment strategies, notably purchasing 5.04 million shares in UnitedHealth Group, which amplifies its position in the healthcare sector. Meanwhile, the FTC is investigating Hims & Hers over questionable advertising and cancellation procedures, indicating potential regulatory challenges ahead for the telehealth platform.

Amidst these developments, Scorpion Capital has taken a short position on Soleno Therapeutics, critiquing the efficacy of its drug, Vykat XR, for Prader-Willi syndrome. Additionally, the draft report from President Trump's 'Make America Healthy Again' commission steers clear of tightening regulations on pesticide use, sparking discussions on agricultural practices and health. In technology, a cyber breach impacting millions at UnitedHealth and Apple's new blood oxygen feature reflect the ongoing interplay between health and tech innovation.

(With inputs from agencies.)